BBP
Virtus Biotech ETF
1W: -1.9%
1M: -7.3%
3M: -4.8%
YTD: -1.3%
1Y: +30.8%
3Y: +67.2%
5Y: +42.2%
$78.28
-0.33 (-0.42%)
Weekly Expected Move ±4.7%
$71
$75
$79
$82
$86
Overview
Chart
Holdings
Changes
Technicals
Analysis
Peers
Institutions
Dark Pool
Short Interest
Weather
ETF-Level Metrics
AUM$32M
Holdings63
Top 10 Wt26.9%
Beta1.06
% Profitable38%
Coverage99%
Portfolio Valuation
P/E28.0
P/B5.4
P/S6.2
EV/EBITDA17.0
P/FCF26.7
PEG2.02
Profitability & Returns
Gross Margin82.6%
Net Margin12.5%
ROE11.2%
ROA5.2%
ROIC12.2%
Div Yield0.10%
Leverage & Liquidity
Debt/Equity0.67
Debt/Assets0.32
Net Debt/EBITDA0.2x
Interest Cov5.3x
Current Ratio2.45
Quick Ratio2.13
Growth (YoY)
Revenue+60.8%
Net Income+48.9%
EPS+54.5%
FCF+45.6%
EBITDA+59.0%
Rev CAGR 3Y+110.6%
Quality Scores
Piotroski F5.0
Altman Z5.14
IS Quality54.1
IS Overall50.2
IS Value42.8
Median P/E-3.4
Sector Breakdown
2 sectors| Sector | # Holdings | Total Weight % | Avg P/E |
|---|---|---|---|
| Healthcare | 61 | 99.5% | -1.5 |
| Other | 3 | 0.5% | — |
Smart Money Overlap
2 holdings with signals
Showing 50 of 64 holdings
· Page 1 of 2
| # | Name | Ticker | Weight % ▼ | Mkt Value | Shares | P/E | Mkt Cap | Sector |
|---|---|---|---|---|---|---|---|---|
| 1 | ImmunityBio Inc | IBRX | 5.01% | $2.6M | 357,747 | -20.8 | $7.6B | Healthcare |
| 2 | Day One Biopharmaceuticals Inc | DAWN | 4.10% | $2.2M | 100,990 | -20.6 | $2.2B | Healthcare |
| 3 | Moderna Inc | MRNA | 2.92% | $1.5M | 28,656 | -6.9 | $19.6B | Healthcare |
| 4 | Iovance Biotherapeutics Inc | IOVA | 2.69% | $1.4M | 383,763 | -3.7 | $1.2B | Healthcare |
| 5 | Mirum Pharmaceuticals Inc | MIRM | 2.19% | $1.2M | 12,987 | -190.0 | $4.4B | Healthcare |
| 6 | Novavax Inc | NVAX | 2.18% | $1.2M | 128,505 | 3.1 | $1.4B | Healthcare |
| 7 | BioCryst Pharmaceuticals Inc | BCRX | 2.03% | $1.1M | 111,529 | 7.5 | $2.0B | Healthcare |
| 8 | Roivant Sciences Ltd | ROIV | 1.98% | $1.0M | 38,202 | -22.8 | $19.0B | Healthcare |
| 9 | Syndax Pharmaceuticals Inc | SNDX | 1.94% | $1.0M | 41,445 | -7.1 | $2.1B | Healthcare |
| 10 | Geron Corp | GERN | 1.82% | $956,024 | 620,795 | -10.9 | $897M | Healthcare |
| 11 | Gilead Sciences Inc | GILD | 1.82% | $959,666 | 7,011 | 19.6 | $166.7B | Healthcare |
| 12 | KalVista Pharmaceuticals Inc | KALV | 1.80% | $946,117 | 49,927 | -5.8 | $990M | Healthcare |
| 13 | Kiniksa Pharmaceuticals International Plc | KNSA | 1.80% | $949,634 | 20,300 | 57.5 | $3.4B | Healthcare |
| 14 | Amgen Inc | AMGN | 1.78% | $937,640 | 2,655 | 24.4 | $188.0B | Healthcare |
| 15 | Axsome Therapeutics Inc | AXSM | 1.78% | $935,982 | 5,698 | -43.2 | $8.0B | Healthcare |
| 16 | Biogen Inc | BIIB | 1.76% | $926,259 | 4,848 | 20.9 | $27.0B | Healthcare |
| 17 | Agios Pharmaceuticals Inc | AGIO | 1.76% | $927,222 | 30,959 | -4.2 | $1.7B | Healthcare |
| 18 | United Therapeutics Corp | UTHR | 1.73% | $909,029 | 1,707 | 17.4 | $22.9B | Healthcare |
| 19 | Ligand Pharmaceuticals Inc | LGND | 1.72% | $907,054 | 4,453 | 31.0 | $3.9B | Healthcare |
| 20 | BioMarin Pharmaceutical Inc | BMRN | 1.67% | $879,690 | 15,836 | 29.8 | $10.4B | Healthcare |
| 21 | Exelixis Inc | EXEL | 1.66% | $874,776 | 20,651 | 14.4 | $11.1B | Healthcare |
| 22 | Krystal Biotech Inc | KRYS | 1.65% | $867,079 | 3,449 | 34.7 | $7.2B | Healthcare |
| 23 | Regeneron Pharmaceuticals Inc | REGN | 1.64% | $861,159 | 1,138 | 16.9 | $76.7B | Healthcare |
| 24 | TG Therapeutics Inc | TGTX | 1.64% | $861,221 | 26,930 | 10.2 | $5.1B | Healthcare |
| 25 | Halozyme Therapeutics Inc | HALO | 1.63% | $858,909 | 13,571 | 22.9 | $7.3B | Healthcare |
| 26 | Vertex Pharmaceuticals Inc | VRTX | 1.61% | $847,133 | 1,867 | 27.8 | $110.0B | Healthcare |
| 27 | Sarepta Therapeutics Inc | SRPT | 1.61% | $850,138 | 39,213 | -2.9 | $2.1B | Healthcare |
| 28 | Ascendis Pharma A/S | ASND | 1.60% | $844,898 | 3,830 | -50.9 | $13.3B | Healthcare |
| 29 | Zai Lab Ltd | ZLAB | 1.58% | $831,918 | 47,511 | -11.3 | $2.0B | Healthcare |
| 30 | Bridgebio Pharma Inc | BBIO | 1.55% | $815,364 | 11,234 | -18.9 | $13.5B | Healthcare |
| 31 | Incyte Corp | INCY | 1.55% | $816,316 | 8,848 | 13.9 | $18.0B | Healthcare |
| 32 | Aurinia Pharmaceuticals Inc | AUPH | 1.48% | $777,698 | 53,267 | 6.7 | $1.9B | Healthcare |
| 33 | BioNTech SE | BNTX | 1.48% | $778,744 | 8,904 | -16.2 | $21.5B | Healthcare |
| 34 | Ardelyx Inc | ARDX | 1.47% | $773,578 | 135,954 | -21.7 | $1.3B | Healthcare |
| 35 | Ionis Pharmaceuticals Inc | IONS | 1.47% | $775,437 | 10,445 | -30.7 | $11.9B | Healthcare |
| 36 | Madrigal Pharmaceuticals Inc | MDGL | 1.45% | $765,690 | 1,476 | -39.7 | $11.7B | Healthcare |
| 37 | PTC Therapeutics Inc | PTCT | 1.42% | $747,720 | 11,160 | 7.8 | $5.5B | Healthcare |
| 38 | Arrowhead Pharmaceuticals Inc | ARWR | 1.39% | $731,975 | 12,045 | 40.0 | $8.1B | Healthcare |
| 39 | Neurocrine Biosciences Inc | NBIX | 1.39% | $731,488 | 5,524 | 26.7 | $12.9B | Healthcare |
| 40 | BeOne Medicines Ltd | BGNE | 1.39% | $732,810 | 2,646 | 170.3 | $20.2B | Healthcare |
| 41 | CRISPR Therapeutics AG | CRSP | 1.35% | $708,210 | 14,894 | -7.1 | $4.4B | Healthcare |
| 42 | Theravance Biopharma Inc | TBPH | 1.34% | $705,788 | 46,464 | 7.2 | $777M | Healthcare |
| 43 | Immunocore Holdings PLC | IMCR | 1.33% | $699,899 | 22,940 | -55.4 | $1.5B | Healthcare |
| 44 | Tarsus Pharmaceuticals Inc | TARS | 1.32% | $697,402 | 10,378 | -42.7 | $2.8B | Healthcare |
| 45 | Alnylam Pharmaceuticals Inc | ALNY | 1.32% | $696,356 | 2,122 | 133.8 | $42.1B | Healthcare |
| 46 | Kura Oncology Inc | KURA | 1.31% | $690,620 | 82,610 | -2.4 | $684M | Healthcare |
| 47 | Travere Therapeutics Inc | TVTX | 1.29% | $676,753 | 24,239 | -49.0 | $2.5B | Healthcare |
| 48 | ACADIA Pharmaceuticals Inc | ACAD | 1.27% | $667,610 | 31,095 | 9.0 | $3.5B | Healthcare |
| 49 | Legend Biotech Corp | LEGN | 1.26% | $661,542 | 37,824 | -10.4 | $3.1B | Healthcare |
| 50 | Arcutis Biotherapeutics Inc | ARQT | 1.24% | $651,079 | 29,092 | -168.6 | $2.6B | Healthcare |